Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Georgi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
EJNMMI Research|September 15, 2021
Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphomaLars Kurch, Ulrich Dührsen, Andreas Hüttmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Interim PET in Diffuse Large B-Cell LymphomaLars Kurch, Andreas Hüttmann, Thomas W Georgi, et al.
Plos One|April 18, 2022
Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptakeThomas W Georgi, Axel Zieschank, Kevin Kornrumpf, et al.
Plos One|April 3, 2020
Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trialThomas W Georgi, Lars Kurch, Dirk Hasenclever, et al.
Plos One|March 28, 2023
Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutionsThomas W Georgi, Lars Kurch, Dirk Hasenclever, et al.
Frontiers in Oncology|February 4, 2022
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case ReportLars Kurch, Thomas W Georgi, Astrid Monecke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive DiseaseRegine Kluge, Tim Wittig, Thomas W Georgi, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
EJNMMI Research|September 15, 2021
Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphomaLars Kurch, Ulrich Dührsen, Andreas Hüttmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 28, 2020
Interim PET in Diffuse Large B-Cell LymphomaLars Kurch, Andreas Hüttmann, Thomas W Georgi, et al.
Plos One|April 18, 2022
Automatic classification of lymphoma lesions in FDG-PET-Differentiation between tumor and non-tumor uptakeThomas W Georgi, Axel Zieschank, Kevin Kornrumpf, et al.
Plos One|April 3, 2020
Quantitative assessment of interim PET in Hodgkin lymphoma: An evaluation of the qPET method in adult patients in the RAPID trialThomas W Georgi, Lars Kurch, Dirk Hasenclever, et al.
Plos One|March 28, 2023
Interobserver variability in interim PET assessment in Hodgkin lymphoma-reasons and solutionsThomas W Georgi, Lars Kurch, Dirk Hasenclever, et al.
Frontiers in Oncology|February 4, 2022
Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case ReportLars Kurch, Thomas W Georgi, Astrid Monecke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 9, 2020
Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive DiseaseRegine Kluge, Tim Wittig, Thomas W Georgi, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 14, 2022
Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma PatientsThomas W Georgi, Dietrich Stoevesandt, Lars Kurch, et al.
JAMA Oncology|January 2, 2025
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical TrialStephen Daw, Alexander Claviez, Lars Kurch, et al.
Pageof 2